Ban the use of genetic test results in insurance and hiring with no exceptions, and have all insurers share the cost
In short
- Insurance companies may not ask for genetic test results or use them in any way.
- Employers may no longer ask for genetic information when hiring or promoting people.
- The rule is written into law, life insurance included, instead of being left to the industry's own promises.
- Insurers together build a fund to cover the losses from many people with higher risk of illness joining.
- The cost no longer falls only on people who got tested, and is spread in small amounts across all policyholders.
If this comes true
A nurse who lost their mother to breast cancer at a young age takes a genetic test without worrying about renewing their insurance, and uses the result to plan checkups with their sister.
Perhaps
People who learn their own risk is high might keep joining large policies, and young families who cannot pay the higher premiums might cancel their insurance.
Water so far 💧 0
The proposal in detail
The rule covers every insurance that an individual buys, such as health insurance, life insurance, and insurance for disability or long-term care, and every stage of employment. The banned information is the results of genetic tests of the person or of blood relatives, whether the person has joined genetic research, and the fact of whether they have been tested at all. Insurers and employers may not ask for any of this, accept it when the person offers it on their own, or buy it from outside sources. Illnesses that have already shown symptoms and been diagnosed stay subject to disclosure as before, and the ban is limited to using genes to predict and act on future illnesses that have not happened yet. Asking about family medical history remains allowed. The problem that people who know they are at high risk join life insurance and similar products in large numbers and unbalance the insurers' burden is handled with a shared fund. For contracts above a certain amount, part of the payouts is covered by a fund that each company pays into in proportion to its share of premiums received, so that no single company is left holding the loss. Companies that break the rule pay fines based on their sales, and any refusal or extra charge based on genetic information is void. An independent body checks every few years how lopsided enrollment is and how premiums are affected, and the companies' shares of the fund are reviewed, but loosening the ban itself is not part of what this review can change.
BenefitsPeople stop fearing tests and can prevent illness earlier
The biggest effect is that whether to get a genetic test can be decided by medical need alone. Once there is no effect on insurance or work, the people at highest risk are the ones who get tested, and the results can lead to earlier checkups and preventive care. Genetic information is shared within a family, so when one person is tested, parents and siblings can also learn their own risk and prepare. Reasons to hesitate about joining research also shrink, data from a wide variety of people is gathered, and medicine is less likely to fit only certain groups. The reason for treating genes specially also becomes clear. Genes cannot be chosen, are fixed before birth, and reach even to family members. Shutting people out of the protections of daily life because of something like that makes them bear a disadvantage unrelated to anything they did. In addition, by absorbing the losses in a shared fund, the setup in which each insurer acts on its own and fears that only risky customers will gather at their company disappears. This answers head-on the biggest reason regulation has not advanced until now.
DrawbacksPremiums rise for everyone, favoring those who know their risk
The cost of this proposal shows up as higher premiums paid by all policyholders, healthy ones included. People who learn their own risk is high have a reason to buy large policies, and insurers who are not told have no choice but to add that cost to everyone's prices. The fund prevents the loss from piling up at one company, but it does not make the loss itself disappear. Even a small increase is heavy for people who hold insurance on a tight household budget, and if some drop their insurance, the prices for those who remain may rise even more. Doubts about fairness also remain. A person already diagnosed with diabetes pays extra, but a person whose genes show a serious future illness does not. Neither is necessarily at fault, yet they are treated differently. Also, if AI becomes able to predict future illness quite accurately from medical records and lifestyle data, a line that bans only genes may lose its meaning, and society will be forced to choose between keeping on widening the ban and accepting a gap. We must also be ready for insurers to pull out of some products and leave fewer insurance options to choose from.
Learn the background
Genetic testing has become much cheaper over the past twenty years, and people can learn in advance that they are prone to cancer or heart disease and prepare, for example by getting more checkups. Even so, many people turn down a test when it is recommended. They fear the result will affect their insurance, their premiums, or their jobs. Some also hesitate to join research, which slows medical progress itself. In many societies the laws are a patchwork. Use is banned in public health insurance, but life insurance is left to the industry's own promises, or exceptions are allowed for high-value contracts. There are three main reasons this does not change. First, insurers argue that if only people who know their risk join, the system cannot last, and this argument is strong, and regulators fear market chaos and hold back. Second, the people who are hurt are hard to see. More people skip a test out of fear than are actually refused, and those people do not speak up. Third, the system has never clearly answered why genes should be treated specially, and how they differ from blood pressure or weight.
Choose them ready to accept their drawbacks too (up to 5)
It helps pay for the server and the AI's planting
This proposal was written in Japanese by AI (claude-opus-5-5, policy version 2026-10-23b) and translated by AI (claude-sonnet-5-5). Nobody has checked the facts. Read the original (日本語) How the AI writes